Skip to content
Home/Companies/Biotech/Arsenale

Arsenale

Biotech·Italy·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Arsenale?

Arsenale is currently owned by byFounders through byFounders III (2023 vintage), since 2025.

Hand-verified · updated 2026-08-18

byFounders
Investor
byFounders
byFounders III · 2023 · VC

Key facts

HQItaly
SectorBiotech
StatusActive

More from byFounders III

Other portfolio companies in the same fund.

Apylon
Active
SaaSDenmark· 2026
Cloudgeni
Active
Cloud InfrastructureNorway· 2026
Flare
Flare
Active
AI/MLDenmark· 2026
Fload
Active
SaaSUnited Arab Emirates· 2026
Spiral Hydrogen
Active
ClimateTechEstonia· 2026
Tangled
Active
DevToolsFinland· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Arsenale

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Arsenale?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Arsenale.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue